Atlas Trials

Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy

Clinical trial NCT02662283 · UNKNOWN

Trial details

NCT number
NCT02662283
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
IGA Nephropathy
Start date
2016-05-01
Primary completion
2016-11-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.